Zykem Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-07-2024
- Paid Up Capital ₹ 0.10 M
as on 04-07-2024
- Company Age 4 Year, 21 Days
- Last Filing with ROC 31 Mar 2022
- Revenue 4541.05%
(FY 2022)
- Profit 806.36%
(FY 2022)
- Ebitda 551.24%
(FY 2022)
- Net Worth 188.87%
(FY 2022)
- Total Assets 33.70%
(FY 2022)
About Zykem Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Satyendra Mishra and Jagrati Madhwani serve as directors at the Company.
- CIN/LLPIN
U85100MP2020PTC053251
- Company No.
053251
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Oct 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Jabalpur, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media
What products or services does Zykem Healthcare Private Limited offer?
Zykem Healthcare Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Syrup, Injectable Products, Industrial Uniforms & Safety Wear, Coated Gloves, Face Mask & Medical PPE Kits, Disposable Gloves, Infusion Syringes & Supplies, Medical Tubes, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Zykem Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyendra Mishra  | Director | 13-Oct-2020 | Current |
| Jagrati Madhwani | Director | 13-Oct-2020 | Current |
Financial Performance and Corporate Structure Insights of Zykem Healthcare.
Zykem Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 4541.05% increase. The company also saw a substantial improvement in profitability, with a 806.36% increase in profit. The company's net worth Soared by an impressive increase of 188.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zykem Healthcare?
In 2022, Zykem Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zykem Healthcare?
Zykem Healthcare has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zykem Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zykem Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
